This is the story of twin sisters, Kanitha and Kanoksri Kumphai from Thailand. Like twins the world over, they were inseparable and continued to do most things together well into their adulthood. Now in their late 40’s, Kanoksri is married with a family of her own, and Kanitha is single. Both sisters were running a….
The Malaysian Society of Hematology’s annual meeting, held earlier this year, took on special significance as it was the first face-to-face conference since the start of the COVID-19 pandemic. Chairperson, Dr. Gan Gin Gin underscored the two-year gap in his message to participants, adding that the meeting’s theme “making sense of new therapies and technology”….
After weeks of anxious anticipation, February 10, 2023, was a day of incredible joy for us as the first shipment of medication successfully arrived in our partner hospital in Laos and soon into the welcoming hands of the patients – specifically young Ammonlath! Journey kicks off! Our journey started a year ago, in Jan 2022,….
Understanding and recognizing the inequities in cancer care around the globe underpins the 2022-24 World Cancer Day theme to Close the Care Gap. The needs are urgent, and the opportunity exists to make progress toward equitable cancer care for all. We must listen to the perspectives of people living with cancer and let those lived….
Bunthan Kahn was diagnosed with chronic myeloid leukemia (CML) in 2017. He’s a tour guide, a husband, a young father, and an avid learner. From traveling far to meet with specialized physicians, to seeking treatment in his country, his journey toward finding hope took perseverance.
In 2011, Carmen developed a fever that lasted for weeks and began losing weight rapidly. After multiple doctors, tests, and misdiagnoses, she finally discovered she had chronic myeloid leukemia. Carmen feared her life was over. She even went so far as to sew her own funeral dress.
Eventually, Carmen learned that her cancer could be managed through oral treatment, but the costs were prohibitive. Luckily her physician was a Max Foundation partner. She was able to enroll in our access program for imatinib at no cost, and all seemed well for a few years—until, that is, she stopped responding to her initial treatment.
